Corticosteroid treatment for melanoma-associated retinopathy: Effect on visual acuity and electrophysiologic findings

Archives of Dermatology

Volumn 140, Issue 10, 2004, Pages 1258-1261

  Jacobzone, Caroline ^a   Cochard Marianowski, Catherine ^a   Kupfer, Ingrid ^a   Bettembourg, Samia ^a   Dordain, Yves ^b   Misery, Laurent ^a   Cochener, Beatrice ^a   Sassolas, Bruno ^a  

^a BREST UNIVERSITY HOSPITAL   (France)

^b Military Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID;

AGED; ARTICLE; AXILLARY LYMPH NODE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MELANOMA ASSOCIATED RETINOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC SYNDROME; PHOTORECEPTOR CELL; PRIORITY JOURNAL; RETINA BIPOLAR GANGLION CELL; RETINA PIGMENT DEGENERATION; RETINOPATHY; UVEITIS; VISUAL IMPAIRMENT;

ADRENAL CORTEX HORMONES; AGED; DIAGNOSIS, DIFFERENTIAL; ELECTROPHYSIOLOGY; FEMALE; HUMANS; MELANOMA; NEOPLASMS, SECOND PRIMARY; PARANEOPLASTIC SYNDROMES; RETINAL DISEASES; SKIN NEOPLASMS; VISION, LOW; VISUAL ACUITY;

EID: 5444235318     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.10.1258     Document Type: Article

References (22)

1. Berson EL, Lessel S. Paraneoplastic night blindness with malignant melanoma. Am J Ophthalmol. 1988;106:307-311.
2. Alexander KR, Fishman GA, Peachey NS, Marchese AL, Tso MO. "On" response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci. 1992;33:477-483.
3. Milam AH, Saari JC, Jacobson SG, Lubinski WP, Feun LG, Alexander KR. Auto-antibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci. 1993;34:91-100.
4. Weinstein JM, Kelman SE, Bresnick GH, Kornguth SE. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma. Ophthalmology. 1994;101:1236-1243.
5. Kim RY, Retsas S, Fitzke FW, Arden GB, Bird AC. Cutaneous melanoma-associated retinopathy. Ophthalmology. 1994;101:1837-1843.
6. Rougier MB, Hostyn P, Bret-Dibat C, Delaunay MM, Riss I, Le Rebeller MJ. Paraneoplastic retinopathy associated with cutaneous melanoma: a case report and update. J Fr Ophtalmol. 1995;18:396-403.
7. Singh AD, Milam AH, Shields CL, De Potter P, Shields JA. Melanoma-associated retinopathy. Am J Ophthalmol. 1995;119:369-370.
8. Remulla JF, Pineda R, Gaudio AR, Milam AH. Cutaneous melanoma-associated retinopathy with retinal periphlebitis. Arch Ophthalmol. 1995;113:854-855.
9. Bret-Dibat C, Rougier MB, Le Rebeller MJ, Delaunay M. Melanoma-associated retinopathy: case report and review of the literature. Bull Cancer. 1996;83:1019-1022.
10. Boeck K, Hofmann S, Klopfer M, et al. Melanoma-associated paraneoplastic retinopathy. Br J Oermatol. 1997;137:457-460.
11. Potter MJ, Thirkill CE, Dam OM, Lee AS, Milam AH. Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy. Ophthalmology. 1999;106:2121-2125.
12. Borkowski LM, Grover S, Fishman GA, Jampol LM. Retinal findings in melanoma-associated retinopathy. Am J Ophthalmol. 2001;132:273-275.
13. Chan C, O'Day J. Melanoma-associated retinopathy: does autoimmunity prolong survival? Clin Experiment Ophthalmol. 2001;29:235-238.
14. Keltner JL, Thirkill CE, Yip PT. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome. J Neuroophthalmol. 2001;21:173-187.
15. De Potter P, Disneur D, Levecq L, Snyers B. Ocular manifestations of cancer. J Fr Ophtalmol. 2002;25:194-202.
16. Ripps H, Carr RE, Siegel IM, Greenstein VC. Functional abnormalities in vincristine-induced night blindness. Invest Ophthalmol Vis Sci. 1984;25:787-794.
17. Feigl B, Faschinger C, Soyer P. Melanoma-associated retinopathy versus abnormal retinal function due to interferon-α/isotretinoin therapy in cutaneous malignant melanoma. Ophthalmologica. 2000;214:271-276.
18. Esmaeli B, Koller C, Papadopoulos N, Romaguera J. Interferon-induced retinopathy in asymptomatic cancer patients. Ophthalmology. 2001;108:858-860.
19. Hejny C, Sternberg P, Lawson DH, Greiner K, Aaberg TM Jr. Retinopathy associated with high-dose interferon alfa-2b therapy. Am J Ophthalmol. 2001;131:782-787.
20. Thirkill CE, Roth AM, Keltner JL. Cancer-associated retinopathy. Arch Ophthalmol. 1987;105:372-375.
21. Thirkill CE, Tait RC, Tyler MK, et al. The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci. 1992;33:2768-2772.
22. Pföhler C, Haus A, Palmowski A, et al. Melanoma-associated retinopathy. Br J Dermatol. 2003;149:74-78.